Author response for "Albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes: a randomized cross‐over clinical study"
Annemarie B. van der Aart‐van der Beek(University of Groningen), Hiddo JL Heerspink, Niels Jongs(University Medical Center Groningen), Ellen M. Apperloo(Dialyse Centrum Groningen), Klaas Hoogenberg(Martini Ziekenhuis), C. David Sjöström(University Medical Center Groningen), Dennis B. Rouw(Martini Ziekenhuis), L. E. B. Johansson(Swedish Institute of Space Physics), Daniël H. van Raalte(Amsterdam University Medical Centers), Iris Friedli(Antaros Medical (Sweden))
Cited by 0
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Bariatric Surgery and Long-term Cardiovascular Events
|JAMA|2012|1.6k